Calamos Advisors LLC Ionis Pharmaceuticals Inc Transaction History

Calamos Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	BUY	$43.39 - $51.63 $710,684 - $845,647	16,379 New	16,379 $828,000
Q4 2022 Jan 25, 2023	SELL	$37.12 - $46.52 $374,652 - $469,526	-10,093 Reduced 58.96%	7,026 $0
Q3 2022 Oct 24, 2022	BUY	$36.54 - $48.66 $625,528 - $833,010	17,119 New	17,119 $757,000
Q3 2019 Oct 21, 2019	SELL	$59.06 - $72.15 $186,039 - $227,272	-3,150 Closed	0 $0
Q2 2019 Aug 07, 2019	BUY	$62.09 - $86.14 $195,583 - $271,341	3,150 New	3,150 $202,000

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.15B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Calamos Advisors LLC with notifications on news.